The Effect of Post-Cardiopulmonary Resuscitation N-acetylcysteine on Renal Function: A Randomized Clinical Trial
Background: The purpose of our study was to determine the effect of N-acetylcysteine (NAC) administered after successful cardiopulmonary resuscitation (CPR) on renal function of the survived patients.
Methods: In this double-blinded randomized clinical trial, 44 patients who experienced cardiopulmonary arrest and underwent successful cardiopulmonary resuscitation (CPR) were entered into the study. They were randomly divided into two groups. One group received NAC (150 mg/kg) and the control group received normal saline (NS).
Results: Serum levels of blood urea nitrogen (BUN), creatinine, and neutrophil gelatinase-associated lipocalin (NGAL) were significantly lower in the NAC group when compared to the NS group at 6, 12,24, 48, and 72 hours after resuscitation. However, alanine aminotransferase (ALT), cardiac troponin, creatine kinase MB fraction (CK-MB) and arterial blood gases did not differ between the two groups.
Conclusion: We observed significantly lower serum levels of BUN, creatinine, and NGAL in patients who received NAC after successful CPR following cardiopulmonary arrest. This can be used in clinical practice to decrease the chance of developing renal failure in such patient population.
Mattana J, Singhal PC. Prevalence and determinants of acute renal failure following cardiopulmonary resuscitation. Arch Intern Med. 1993; 153(2):235-9.
Bulut S, Aengevaeren WR, Luijten HJ, Verheugt FW. Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy? Resuscitation. 2000; 47(2):155-61.
Lameire N, Van BW, Vanholder R. Acute renal failure. Lancet. 2005; 365(9457):417-30.
Domanovits H, Schillinger M, Müllner M, Thoennissen J, Sterz F, Zeiner A, et al. Acute renal failure after successful cardiopulmonary resuscitation. Intensive Care Med. 2001; 27(7):1194-9.
Hasper D, von Haehling S, Storm C, Jörres A, Schefold JC. Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study. Crit Care. 2009; 13(5):R168.
Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16(11):3365-70.
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365(9466):1231-8.
Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008; 241:89-94.
Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol. 2009; 53(3): 261-6.
Dinicola S, De Grazia S, Carlomagno G, Pintucci JP. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. Eur Rev Med Pharmacol Sci. 2014; 18(19):2942-8.
Bateman DN, Dear JW, Carroll R, Pettie J, Yamamoto T, Elamin ME, et al. Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience. Clin Toxicol (Phila). 2014; 52(8):868-72.
De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, et al. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest. 2000; 30(10):915-29.
Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008; 8(12):1955-62.
Adair JC, Knoefel JE, Morgan N. Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease. Neurology. 2001; 57(8):1515-7.
Liu R, Nair D, Ix J, Moore DH, Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med. 2005; 20(2):193-200.
Efrati S, Dishy V, Averbukh M, Blatt A, Krakover R, Weisgarten J, et al. The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int. 2003; 64(6):2182-7.
Smith, Trevor. Ethics in medical research. Cambridge, UK: Cambridge University Press, 1999. p. 12–49.
Lee TF, Tymafichuk CN, Bigam DL, Cheung PY. Effects of postresuscitation N-acetylcysteine on cerebral free radical production and perfusion during reoxygenation of hypoxic newborn piglets. Pediatr Res. 2008; 64(3):256-61.
Liu JQ, Lee TF, Chen C, Bagim DL, Cheung PY. N-acetylcysteine improves hemodynamics and reduces oxidative stress in the brains of newborn piglets with hypoxia-reoxygenation injury. J Neurotrauma. 2010; 27(10):1865-73.
Lee JH, Jo YH, Kim K, Lee JH, Rim KP, Kwon WY, et al. Effect of N-acetylcysteine (NAC) on acute lung injury and acute kidney injury in hemorrhagic shock. Resuscitation. 2013; 84(1):121-7.
Gundersen Y, Vaagenes P, Thrane I, Sterri SH, Opstad PK. N-Acetylcysteine administered as part of the immediate post-traumatic resuscitation regimen does not significantly influence initiation of inflammatory responses or subsequent endotoxin hyporesponsiveness. Resuscitation. 2005; 64(3):377-82.
Silbergleit R, Haywood Y, Fiskum G, Rosenthal RE. Lack of a neuroprotective effect from N-acetylcysteine after cardiac arrest and resuscitation in a canine model. Resuscitation 1999; 40: 181-6.
Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, et al. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med. 2000; 28(12):3799-807.